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Volume 58, Number 2 Abstracts 557by claudication, CLI, and aneurysmal disease treated with an Endologix
abdominal endograft.
Methods: A retrospective review of all endovascular aorto-iliac aneu-
rysms repaired with an Endologix device was perfomed at a single institution
between January 2008 and April 2013. This revealed 51 patients who were
treated with the Endologix device for aorto-iliac aneurysms who had coex-
isting aortoiliac occlusive disease. Patient demographics, procedural details,
and clinical follow-up were reviewed.
Results: All nine (100%) of the patients had claudication and three
(33%) had CLI. One patient presented with an aortic rupture and the
remaining eight patients were elective. Successful deployment of the endo-
vascular device was achieved in all nine (100%) patients. There was no 30-
day mortality or reintervention within 1 year. Of the nine patients, three
(33%) had complete iliac occlusions which were all crossed utilizing an
Outback re-entry device. The remaining six (66%) patients all had iliac
stenoses and two (22%) also had aortic stenoses. Preprocedural and postpro-
cedural ABIs were available in 8 of 9 patients. Mean bilateral preprocedure
ABI was 0.70 which increased to 0.86 postprocedure.
Conclusions: Signiﬁcant coexisting arterial disease may be encoun-
tered in patients with aortic or iliac aneurysms. Identiﬁcation of coexisting
arterial diseases is essential to help tailor treatment for coexisting occlusive
and aneurysm disease. The Endologix abdominal endograft has properties
that perform well in this patient population in our single-center review.
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Objectives: Early hospital readmission among vascular surgery
patients has become a focus for the restructuring of Medicare's reimburse-
ment system; however, risk factors for these readmissions remain poorly
characterized. We aim to identify factors associated with 30 day readmission
after peripheral artery interventions.
Methods: Retrospective analysis of 175 consecutive patients dis-
charged between 1/1/2011-7/31/2012 who underwent treatment for
lower extremity peripheral artery disease, which included open and endovas-
cular aortoiliac procedures, infrainguinal revascularizations, and amputa-
tions. Data on demographics, comorbidities, length of stay, type of
operation performed, and functional status were acquired from the elec-
tronic medical record.Table. Patient characteristics
Nonreadmission
group
Readmission
group P value
Total 133 37
Age 69 0 6 11.4 68.7 6 11.4 .87
Male gender 67% 54% .15
Race .33
White 93 (67%) 23 (62%)
Black 12 (9%) 5 (14%)
Hispanic 15 (11%) 2 (5%)
Asian 10 (7%) 6 (16%)
Others 8 (6%) 1 (3%)
Diabetes mellitus 69 (50%) 14 (38%) .18
Hypertension 113 (83%) 33 (89%) .33
Coronary artery disease 54 (39%) 14 (37%) .86
Congestive heart failure 17 (12%) 4 (11%) .8
Hyperlipidemia 78 (57%) 18 (49%) .39
Stroke 19 (14%) 4 (11%) .64
Chronic kidney disease 22 (16%) 12 (33%) .02
End stage renal disease 13 (9%) 6 (16%) .24
Chronic pulmonary obstructive
disease
24 (17%) 7 (19%) .83
Smoking 93 (67%) 21 (57%) .23
Venous thromboembolism 8 (6%) 2 (5%) .93
Atrial ﬁbrillation 15 (11%) 5 (14%) .65
Length of stay, days 7.74 7.65 .65
Urgency of operation 24 (17%) 13 (35%) .02
Functional status at discharge .08
Ambulatory 120 (87%) 28 (76%)
Wheelchair-bound 14 (11%) 5 (13%)
Bedbound 4 (3%) 4 (11%)Results: 37/175 (21%) patients were readmitted within 30 days of
discharge; 7/37 (19%) readmissions were planned. There were no signiﬁ-
cant differences in demographic characteristics, comorbid conditions, length
of hospital stay, or discharge functional status between the readmitted and
nonreadmitted groups (Table). Readmitted patients were more likely to
have undergone an urgent operation (P ¼ .02). In a multivariate logistic
regression model, urgency of operation (OR, 3.42; 95% CI, 1.35-8.67)
and either chronic kidney disease or end stage renal disease (OR, 3.71;
95% CI, 1.39-9.91) were signiﬁcantly associated with increased risk of 30
day readmission. Diabetes mellitus was associated with a lower risk of read-
mission (OR, 0.32; 95% CI, 0.12-0.83). The most common reasons for
readmission were infection, either of the surgical site or index limb (18/
37 ¼ 49%) followed by persistent nonhealing wounds or rest pain in the
index limb (11/37 ¼ 30%). Graft failure requiring reintervention accounted
for 3/37(8%) of readmissions.
Conclusions: Thirty-day readmission is frequent after peripheral artery
interventions, with themajority of these related to the index limb.Urgent oper-
ative intervention and compromised renal function appear to be risk factors for
early hospital readmission.
Lower Extremity Autogenous Vein Bypass for Critical Limb Ischemia
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Objectives: It has been reported a failed endovascular intervention
adversely affects results of lower extremity bypass (LEB). We reviewed rates
of prior endovascular intervention in patients undergoing LEB with autolo-
gous vein for critical limb ischemia (CLI) to determine effects on graft
patency, limb salvage and amputation free survival (AFS).
Methods: Review of consecutive autologous vein LEBs performed for
CLI between 2005 and 2012 at a tertiary care academic medical center.
Results: Overall there were 311 autologous vein LEBs performed for
CLI; 70% for tissue loss. TASC D or C lesions were present in 61% and
25%, respectively. The greater saphenous vein was used as a conduit in 83%
and the distal target was infra-popliteal in 60%. 30-day mortality was 3.5%.
One and 5-year primary patency was 61% and 45%.One and 5-year secondary
patency was 88% and 65%, with 23% requiring an intervention to maintain
patency. Five-year limb salvage was 90% and 5-year AFS was 49%.
Sixty patients (19%) had undergone a prior ipsilateral endovascular
intervention (PEI) and 251 were felt to be unsuitable for an endovascular
intervention (NPEI). PEI and NPEI patients had similar demographics
and prevalence of atherosclerotic risk factors. One-year primary and
secondary patency were 61% and 87% for PEI patients and 60% and 89%
for NPEI patients (P ¼ NS). Three-year secondary patency was 76% for
PEI and 68% for NPEI (P ¼ NS). Three-year limb salvage was 94% for
PEI vs 89% for NPEI (P ¼ NS). Three-year AFS was 53.6% for PEI vs
59.1% for NPEI (P ¼ NS).
Conclusions: Overall operative mortality, patency rates and limb
salvage for autologous vein LEB in CLI patients continue to be excellent
in the endovascular era and are not necessarily affected by a prior failed ipsi-
lateral endovascular procedure. Long-term survival remains poor in CLI
patients requiring LEB.
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Objectives: To evaluate the efﬁcacy of endovascular therapy in failing
infrapopliteal bypass grafts to maintain patency and preserve limbs.
Methods: This is a retrospective review of endovascular procedures to
preserve graft patency. Data were derived from a registry of catheter-based
procedures for peripheral artery disease and review of records and angio-
graphic images. Of 1554 arteriograms performed from 2006 to 2012, there
were 44 interventions in 35 patients for failing bypass vein grafts to infrapo-
pliteal target vessels. The ﬁrst intervention for each patient was used in this
analysis. Duplex ultrasound scanning (DUS) was routinely used within 30
days and at 3-6 month intervals for graft surveillance.
Results: Interventions were performed for recurrent symptoms of
critical limb ischemia in 43% and for stenoses identiﬁed by DUS in 57%.
Procedural techniques included cutting balloon angioplasty (74%), conven-
tional balloon angioplasty (14%), stent placement (9%), and laser atherec-
tomy and thrombectomy (3%). Procedural success was achieved in 34 of
35 cases (97%). There were no procedure-related complications,
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DUS in seven patients; one had early endovascular reintervention and one
had early surgical graft revision. Median follow-up time was 531 days.
Kaplan-Meier analysis showed limb salvage rates of 93% at both 12 and
24 months; continued graft patency rates without need for reintervention
were 29% and 24%. Receiver operating characteristic analysis identiﬁed that
a lesion length of 1.5 cm maximized sensitivity and speciﬁcity in predicting
restenosis (C statistic: 0.81); the restenosis rate for patients with lesions
>1.5 cm was 100% at one year, and for lesions #1.5 cm was 43% at one
year and 54% at two years (P < 0.001 by log rank test).
Conclusions: In this single-center experience with endovascular ther-
apies to treat failing infrapopliteal bypass grafts, 93% of limbs were
preserved, but over 70% of patients developed graft restenosis within 12
months. In particular, stenoses longer than 1.5 cm did very poorly with
endovascular treatment. These data suggest that interventions to restore
or prolong graft patency are effective in preventing limb loss and that close
follow up with vascular laboratory surveillance is essential.
Fig.
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Objectives: Assess charges, case complexity and use of revasculariza-
tion among inpatient hospital admissions for diabetic foot infections
(DFIs) and associated amputations in the U.S. over 10 years.
Methods: Inpatient discharge records from the Agency for Health-
care Research and Quality Healthcare Cost and Utilization Project were
used in this retrospective cohort study spanning 2001-2010. We reviewed
all-listed diagnoses of inpatient DFIs, stratiﬁed by open bypass (Open) or
endovascular therapy (EVT) and major (above ankle) or minor amputation.
Revascularization, length of stay (LOS), case complexity and hospital
charges were analyzed on a per admission basis.
Results: During the study period, 2.5 million inpatient DFI cases
were observed, of which 412,051 (16.5%) involved amputation (34.8%
major, 61.2% minor). Overall, 211,534 (8.5%) of DFI cases underwent
revascularization (43.5% Open, 51.1% EVT, 5.4% both). From 2001 versus
2010, the volume of Open procedures decreased to 34.9%, while EVT
volume rose to 297.1%. Some 6.7% of the 143,470 major amputations
involved revascularization during the same hospital stay (29.8% Open,
63.5% EVT, 6.7% combination) versus 15.1% of the 268,520 minor ampu-
tations (44.9% Open, 44.2% EVT, 6.9% combination). In amputation-only
cases, from 2001 versus 2010, Open volume fell 27.3% but EVT increased
280.3%. Minor amputations increased 48.5%, but major amputations only
rose 7.7%. Notably, an increasing case-mix severity was seen for amputations
with associated vascular procedures, with a 25.5% increase in unadjusted
mean charges ($104,839 vs $131,554, US2012). However, mean LOS
decreased 22.5% (18.4 vs 14.2 days; P < .05). Inpatient amputation-relatedmortality was 1.8%, falling by 19.1% from 749 (2.2%) in 2001 to 606 (1.3%)
in 2010.
Conclusions: This nationally representative investigation found that
DFI admissions are common, long, and ever more costly (> $100,000/
case), likely due to increasing case severity mix. More DFI patients are
undergoing revascularization (8.5% per admission), with a dramatic shift
from Open bypass to EVT. Despite these unfavorable factors, hospital
mortality and LOS have fallen signiﬁcantly. Major amputation for DFI
also appears to be ﬂattening, with a marked rise in minor amputations
(high:low ratio ¼ 0.57).
Midterm Outcomes of Neuroischemic and Ischemic Wounds Treated
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Objectives: Multidisciplinary limb salvage teams have been shown to
decrease the frequency of major amputations by increasing the rate of
revascularization procedures and minor amputations. The outcomes of
wound healing, recurrence and ambulatory status in multidisciplinary
amputation prevention clinics are assumed to be improved but are not
routinely reported. This study investigates the midterm outcomes of
ischemic and neuroischemic wounds treated at our multidisciplinary limb
salvage clinic.
Methods: A retrospective review of patients treated at a single institu-
tion multi-disciplinary limb salvage clinic over 12 consecutive months. Only
patients with ischemic or neuroischemic wounds were included in the anal-
ysis. Patient demographics, wound characteristics, procedural details, clinical
outcomes and ambulatory status were reviewed. Clinical endpoints under
study included time to wound healing, reulceration rate and ambulatory
status.
Results: Over the study period there were 141 new patients and
901 clinic visits. 80 patients were treated for neuroischemic or ischemic
wounds. In 64% of patients (51/80) wounds were present for >6 weeks
before referral. Previous vascular surgical history was present in 34% (27/
80) and 23% (18/80) had a previous minor amputation. 40% of wounds
(32/80) were limited to the toes or the forefoot whereas 21% (18/80)
involved the rearfoot or ankle. A total of 62 vascular interventions were
performed with an equal distribution of endovascular and open revascu-
larizations. 56% of wounds (45/80) were fully healed over the observa-
tion period. The average time to fully healed was 16 weeks. Rearfoot
or ankle wounds were predictive of failure to heal (OR, 0.32; 95% CI,
0.10-0.99; P < .05). 16% of patients (13/80) developed a new wound
on the ipsilateral leg during follow up. On initial evaluation 56% (45/
80) of patients were fully ambulatory without assistance. After treatment,
13% of patients (10/80) had a net deterioration in their ambulatory
status.
Conclusions: Multidisciplinary limb salvage teams effectively heal
wounds and maintain ambulatory status in patients with ischemic and neu-
roischemic wounds. Patient speciﬁc factors, such as rearfoot or ankle
wounds, can adversely effect on the outcome. Even with high quality
care, 16% of patients can be expected to have a recurrence.
Split Thickness Skin Grafts in High-Risk Extremity Wounds: Helpful
or Heretical?
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Objectives: The use of split thickness skin grafts (STSG) in people
with chronic wounds has often been considered undesirable because of
the perceived high incidence of failure, especially when applied to neuro-
pathic patients with plantar diabetic foot wounds. The purpose of this study
was to report the outcomes of STSG for chronic lower extremity wounds.
Methods: We carried out a retrospective chart review of all consecu-
tive patients undergoing STSG for chronic lower extremity wounds per-
formed by all vascular and podiatric surgeons at our institution from 2007
to April 2013.
Results: A total of 94 patients received STSG for chronic wounds; 70%
were male, with a mean age of 61 years. 66 were performed in people with dia-
betes and 28 were on patients with venous leg ulcers or other chronic nondia-
betic wounds. Sixty-six patients (70%) healed their wounds; 20% required
revision, 9% went on to heal after revision; 5% failed to heal and requiredmajor
limb amputation.
Among the 66 patients with diabetes, 46 (70%) patients healed
primarily after STSG without revision. Forty of these diabetic patients
(60%), all but one of whom was ambulatory, had plantar wounds treated
with STSG, and 65% of these healed primarily. Nine patients with plantar
wounds STSG required revision, four healed after revision. The other
